SummitTX Capital’s Medpace MEDP Stock Holding History

SummitTX Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-974	Closed	-$501K	–	872
2025 Q3	$501K	Buy	+974	New	+$425K	0.02%	526

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SummitTX Capital's MEDP Position: Q4 2025 in Review

SummitTX Capital sold out of Medpace (MEDP) in Q4 2025, closing a stake of 974 shares — an estimated $501K sold.

SummitTX Capital first reported a position in MEDP in Q3 2025 and held it in 1 quarter. The position peaked at $501K in Q3 2025. 785 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

SummitTX Capital reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
SummitTX Capital sold 974 Medpace shares in Q4 2025, an estimated $501K.
SummitTX Capital first reported a position in Medpace in Q3 2025 and held it in 1 quarter.
SummitTX Capital's Medpace position peaked at $501K in Q3 2025.
785 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.